CClinicalTrials.gg
CompletedNCT04085874Updated Sep 11, 2019

Effectiveness of Food-Based Recommendations for Minangkabau Women of Reproductive Age With Dyslipidemia

An interventional study of Promotion of Food-based recommendations and Nutrition counseling from standard health services care in Dietary Habits, Nutrient Deficiency and Obesity, sponsored by Politeknik Kesehatan Kemenkes Padang. Completed at 1 site in Indonesia. Open to female participants aged 20 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-11.

Sponsored by Politeknik Kesehatan Kemenkes Padang · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jan 2019, registered Sep 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
123
Allocation
Randomized
Ages
20 Years to 44 Years
Sex
Female
01

Study summary

This study aimed to assess effectiveness of promoting the optimized Food-based recommendations (FBRs) for improving dietary practices, nutrient intakes, nutritional status and lipid profile among Minangkabau women of reproductive age with dyslipidemia in a community setting. A cluster randomized community-based trial was conducted in Padang City, West Sumatra, Indonesia. Subjects are Minagabau women of reproductive age (20-44 y) with dyslipidemia. The subjects were assigned either into FBR group (n=48) that involved in 12-weeks prolonged contact of FBRs promotion or into non-FBR group, that received once nutrition counselling from usual standard of nutrition program. Baseline and end-line lipid profiles, nutritional status, dietary practice and nutrient intake data were assessed through biochemical assessment, anthropometri, and interview structured questionaire.

Read the detailed description

This study was conducted in two sequential phases. The first stage was a formative phase in the form of observational survey to develop and validate food-based recommendations (FBRs). The second phase was an intervention study to assess the effectiveness of the FBRs in improving dietary practice, the intake of problem nutrient, nutritional status and lipid profile of the subject.

Sample size for intervention per group (n=60/group; 2 groups) was expected to detect mean(±SD) differences in LDL-cholesterol concentration (as an secondary outcome) of 14±20 mg/dL as observed in a previous study in other area, with assumption of 80% power and 25% loss of follow up. Potential subjects were identified prior to dyslipidemia screening before intervention. Field nutritionist and volunteer cadres were requested to identify and list women of reproductive age fulfilling the inclusion criteria living in selected sites. An invitation letter was sent to all identified eligible subjects to visit appointed field laboratory to perform blood measurement. Inform consent was signed by all potential participants before blood measurement.

This study did not compare an intervention group (FBR group) with a true control group, but with a comparison group that received once nutrition counselling from usual nutrition health program (non-FBR group). Drawing on concepts of Plan Behavior Theory, persuasive FBR promotion was designed to influence subjects' attitude, subjective norms, perceive behavior control related to dyslipidemia and dietary management, and intention to change. Participants were prompted to set goals for themselves to improve their dietary practices in order to fulfill their nutrient requirements, improve nutritional status and lipid profile.

02

Conditions studied

  • Dietary Habits
  • Nutrient Deficiency
  • Obesity
  • Dyslipidemias

Browse trials for

Keywords

  • Nutrition intervention
  • Food-Based Recommendations
  • dietary practices
  • women of reproductive age
  • dyslipidemia
03

In context

Dyslipidemias

1,073 studies on the registry are indexed under Dyslipidemias; 158 are open to participants now.

This study's enrollment of 123 is above the median of 99 across 842 interventional studies indexed under Dyslipidemias.

Browse Dyslipidemias studies →

Lead sponsor

Politeknik Kesehatan Kemenkes Padang is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • women of reproductive age (20-44 years);
  • native Minangkabau ethnic (both father and mother from the Minangkabau tribe);
  • had abnormal one of isolated blood lipid profiles (cholesterol > 200 mg / dl, LDL-cholesterol >100 mg / dl, HDL \< 60 mg/dl, TG > 150 mg/dl);
  • signing a written inform consent.

Exclusion criteria

Exclusion Criteria:

  • in pregnancy;
  • having a history or active smoker and alcoholic addict;
  • has a history of heart disease, diabetes, asthma, cancer, chronic digestive tract disorders, hemophilia and other chronic diseases;
  • routinely taking cholesterol-lowering or blood pressure medications;
  • vegetarians;
  • use estrogen therapy;
  • are participating in other studies.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
123 participants (actual)

Study arms

  • Experimental
    FBR group

    weekly home visit and monthly group meeting for 12 weeks

    Behavioral: Promotion of Food-based recommendations

  • Active comparator
    non-FBR group

    once nutrition counseling from standard health care services

    Behavioral: Nutrition counseling from standard health services care

Interventions

  • BehavioralPromotion of Food-based recommendations

    Prolonged contact through weekly home visits and monthly group meeting for 12 weeks

    Also known as: Nutrition education

  • BehavioralNutrition counseling from standard health services care

    once nutrition counselling from health services

    Also known as: Standard nutrition care

06

What researchers measure

Primary outcomes

  1. Change in Dietary practice

    Change in food consumption from baseline at 12-week intervention, evaluated based on participant's compliance to the Optimized Food-Based Recommendations. The compliance were measured using one-week Food Frequency Questionnaire (FFQ), stated in servings/week for staple foods. snacks, animal protein (sea fish, eggs, poultry), soy protein (tofu/tempeh), potato, fruits,dark green vegetables (DGLV), total vegetables and fried foods. The recommendations (servings/week) for those food groups/items was 14-21, 7-14, minimum 5, 3-4, 2-3,minimum 7,minimum 5, minimum 7, minimum 5, minimum 14, and maximum 14 respectively. Those who complied with the recommendations was scored 1 for each recommendations, and 0 for those who did not. The total score for the compliance to the FBRs was 0-11. Higher score represents better participant's compliance

    Time frame: baseline (before the intervention) and end-line (after 12-weeks intervention)

  2. Change in energy intake

    Change from baseline at 12-week intervention for energy intake( in Kcal). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  3. Change in protein intake

    Change from baseline at 12-week intervention for protein intake( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  4. Change in total fat intake

    Change from baseline at 12-week intervention for total fat intake( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  5. Change in carbohydrate intake

    Change from baseline at 12-week intervention for carbohydrate intake ( in gram)

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  6. Change in poly unsaturated fatty acids (PUFA) intake

    Change from baseline at 12-week intervention for PUFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  7. Change in mono unsaturated fatty acids (MUFA) intakes

    Change from baseline at 12-week intervention for MUFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  8. Change in saturated fatty acids (SFA) intakes

    Change from baseline at 12-week intervention for SFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  9. Change in PUFA/SFA (P/S) ratio

    Change from baseline at 12-week intervention for P/S

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  10. Change in dietary fiber intakes

    Change from baseline at 12-week intervention for dietary fiber intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  11. Change in iron (Fe) intake

    Change from baseline at 12-week intervention for iron intake ( in mg). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  12. Change in zinc (Zn) intake

    Change from baseline at 12-week intervention for zinc intake ( in mg). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

Secondary outcomes

  1. Change in Body weight

    Change in Body weight (in Kg) from baseline at 12-week intervention

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  2. Change in waist circumference

    change of waist circumference (in cm), from baseline at 12-week intervention

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  3. Change in total cholesterol level

    Change of total cholesterol (in mg/dL) from baseline at 12-week intervention

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  4. Change in Low Desnsity Lipoprotein (LDL) cholesterol

    Change of LDL (in mg/dL) from baseline at 12-week intervention

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  5. Change in serum High Density Lipoprotein (HDL) cholesterol

    Change of HDL (mg/dL) from baseline at 12-week intervention

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  6. Change in serum triglyceride (TG)

    Change of TG (mg/dL) from baseline at 12-week intervention

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

Other outcomes

  1. Change in Body Mass Index

    Change in body mass index (kg/m2) from baseline at 12-week intervention, calculated from body weight (in kg) divided by square body height (in meter suquare), endline minus baseline

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

  2. Change in Castelli's Index

    Change of Castelli's index from baseline at 12-week intervention, calculated from the total cholesterol level divided by serum HDL

    Time frame: baseline (before intervention and end-line (after 12-weeks interventions)

07

Study locations

1 site
  • Dinas Kesehatan Kota Padang
    Padang, West Sumatra 25171, Indonesia
08

References and documents

Publications

  • Gusnedi G, Fahmida U, Witjaksono F, Nurwidya F, Mansyur M, Djuwita R, Dwiriani CM, Abdullah M. Effectiveness of optimized food-based recommendation promotion to improve nutritional status and lipid profiles among Minangkabau women with dyslipidemia: A cluster-randomized trial. BMC Public Health. 2022 Jan 6;22(1):21. doi: 10.1186/s12889-021-12462-5. PubMed 34991541 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04085874
Lead sponsor
Politeknik Kesehatan Kemenkes Padang
Collaborators
Indonesia University
Responsible party
Gusnedi (Associate Professor, Politeknik Kesehatan Kemenkes Padang) — Principal investigator
First posted
Sep 11, 2019
Start date
Jan 7, 2019
Primary completion
May 5, 2019
Completion
Jun 10, 2019
Last update
Sep 11, 2019

Study contacts

Murdani Abdullah
study chair · Indonesia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion